The relationship between body mass index and cardiopulmonary exercise testing in chronic systolic heart failure.

Full Abstract

BACKGROUND: Cardiopulmonary exercise testing (CPX) in patients with systolic heart failure (HF) is important for determining HF prognosis and helping guide timing of heart transplantation. Although approximately 20% to 30% of patients with HF are obese (body mass index [BMI] >30 kg/m(2)), the impact of BMI on CPX results is not well established. The objective of this study was to assess the relationship between BMI and CPX variables, including peak oxygen uptake (VO(2)) at ventilatory threshold, oxygen pulse, and ventilation-carbon dioxide production ratio. METHODS: Consecutive patients with systolic HF (n = 2,324) enrolled in the Heart Failure and A Controlled Trial Investigating Outcomes of Exercise Training trial who had baseline BMI recorded were included in this study. Subjects were divided into strata based on BMI: underweight (BMI <18.5 kg/m(2)), normal weight (BMI 18.5-24.9 kg/m(2)), overweight (BMI 25.0-29.9 kg/m(2)), obese I (BMI 30-34.9 kg/m(2)), obese II (BMI 35-39.9 kg/m(2)), and obese III (BMI > or = 40 kg/m(2)). RESULTS: Obese III, but not overweight; obese I; or obese II was associated with decreased peak VO(2) (mL kg(-1) min(-1)) compared to normal weight status. Increasing BMI category was inversely related to ventilation/carbon dioxide production (V(E)/V(CO2)) ratio (P < .0001). On multivariable analysis, BMI was a significant independent predictor of peak VO(2) (partial R(2) = 0.07, P < .0001) and V(E)/V(CO2) slope (partial R(2) = 0.03, P < .0001) in patients with chronic systolic HF. CONCLUSIONS: Body mass index is significantly associated with key CPX fitness variables in patients with HF. The influence of BMI on the prognostic value of CPX in HF requires further evaluation in longitudinal studies.

Author information

Author/s: Horwich, Tamara B (TB); Leifer, Eric S (ES); Brawner, Clinton A (CA); Fitz-Gerald, Meredith B (MB); Fonarow, Gregg C (GC); HF-ACTION Investigators;

Affiliation: Ronald Reagan-UCLA Medical Center, Los Angeles, CA 90095-1679, USA.

Grants: 5U01-HL063747 (Agency:NHLBI NIH HHS) ; 5U01-HL066461 (Agency:NHLBI NIH HHS) ; HL064250 (Agency:NHLBI NIH HHS) ; HL064257 (Agency:NHLBI NIH HHS) ; HL064264 (Agency:NHLBI NIH HHS) ; HL064265 (Agency:NHLBI NIH HHS) ; HL066482 (Agency:NHLBI NIH HHS) ; HL066491 (Agency:NHLBI NIH HHS) ; HL066494 (Agency:NHLBI NIH HHS) ; HL066497 (Agency:NHLBI NIH HHS) ; HL066501 (Agency:NHLBI NIH HHS) ; HL068973 (Agency:NHLBI NIH HHS) ; HL068980 (Agency:NHLBI NIH HHS)

Journal and publication information

Publication Type: Journal Article; Randomized Controlled Trial; Research Support, N.I.H., Extramural

Journal: American heart journal (Am Heart J), published in United States. (Language: eng)

Reference: 2009-Oct; vol 158 (issue 4 Suppl) : pp S31-6

Dates: Created 2009/09/28; Completed 2009/10/29;

PMID: 19782786, status: MEDLINE (last retrieval date: 10/29/2009, IMS Date: )

Sourced from the National Library of Medicine. Abstract text and other information may be subject to copyright.

External Links for this article
(including full text providers, if available):

Click Electronic Full-text Provider Links to see options for finding the electronic full text links to this article. Note there may be a subscription or fee required for access to the full text. See our FAQ for information on finding FREE full text articles.

This article may also be located in paper journal collections available in many libraries. Use the Journal and Publication Information above to find the full article.